Minister of State (Independent Charge) for AYUSH,
Shri Shripad Yesso Naik inaugurated the World Integrated Medicine Forum on
Regulation of Homeopathic Medicinal Products: National and Global strategies in
New Delhi today. Speaking on the occasion, the AYUSH
Minister said that in India, Homoeopathy has been well institutionalized and we
have 235 homoeopathic hospitals and more than 8000 clinics in public sector. He
said that most of production plants in India are GMP-compliant and adhere to
policies related to quality, packaging and distribution. He further said that
all these manufacturing units are bound by Drugs & Cosmetics Law and their
renewal of license depends on regular quality check and thorough inspections.
In his inaugural address, Shri Shripad Naik remarked
that there is clearly a need for a high-level strategic exchange platform,
where stakeholders can meet outside their immediate work related context and
this forum could address that need. In the other countries Homoeopathy remains
largely under-utilized due to lack of availability of homoeopathic medicines or
stringent or non-existent regulatory provisions for these medicines, the
Secretary, Ministry of AYUSH, Sh. Ajit M. Sharan
also expressed his happiness that the Ministry, through CCRH, could demonstrate
global leadership by hosting this unique event. Director General, CCRH, Dr.
Raj K. Manchanda, hoped that this forum could provide impetus to further
dialogues for strengthening regulatory framework worldwide, to assure that the
users of Homoeopathy could have wider access to quality-assured homoeopathic
medicines. Dr. Robbert van Haselen, Director of the WIMF and also the
international consultant for the forum, thanked the Government of India for
spearheading this challenging task of bringing together the regulators and
homeopathic industrialists from so many countries on a common platform to
exchange their concerns and issues.
this occasion an MoU was also signed between Homoeopathic Pharmacopoeia Convention
of the United States (HPCUS) and Indian bodies – Pharmacopoeia Commission for
Indian Medicine & Homoeopathy (PCIM&H) and Central Council for Research
in Homoeopathy (CCRH) on cooperation in the field of Homoeopathic Medicine. It
is hoped that this agreement will be a benchmark for many more agreements to
follow with the aim to develop and harmonise homoeopathic pharmacopoeias and to
strengthen regulatory provisions for homoeopathy in the whole world.
two day event is organised by Ministry of AYUSH and Central Council for
Research in Homeopathy (CCRH) and supported by Pharmacopoeia Commission for
Indian Medicine & Homoeopathy (PCIMH) & Central Drugs Standard Control
Organization (CDSCO). This is the first-of-its-kind forum considering the increased
perception of the international world towards India as a key player in the
progress of the homoeopathy drug industry. Drug lawmakers, regulators,
manufacturers and pharmacopeial experts from various regulatory authorities,
eminent scientific organisations and pharmaceutical industries from 25
countries, are participating in the two days forum to strategize the
actionable aspects in the homoeopathic drug industry, which, in turn, will
promote global harmonisation in the sector.
Through this forum, regulators from more than 15
countries including France, Germany, Switzerland, Sri Lanka, Bangladesh, India
etc .will share the current status, challenges and outlook with regard to the
regulation of homeopathic products. At least 15 international industries
manufacturing homoeopathic medicines and more than 30 Indian industries are participating
and interacted with the drug regulators and controllers. Regulators and drug
controllers of various states of India are also particpaing in the Forum. Forum
discussions will explore the commonalities as well as differences in regulatory
affairs among various countries. The common concern is how to promote
regulatory practices that met the highest modern standards, whilst at the same
time respected the unique tradition of homeopathy worldwide.
Major points of discussion will include current
regulatory status in different countries; practices and possible trade
opportunities in key countries worldwide; possible solutions to regulatory
challenges; building knowledge and network to deal more efficiently with
challenges at national and global level and a strategic perspective on the
possibilities and limitations of what can be achieved at a national level via
further international collaboration and harmonization.
India, homoeopathic medicines are regulated by Drugs & Cosmetics Act &
Rules. All pharmaceutical industries are legally bound to comply with these
rules, which, in turn, assures safety and quality of homoeopathic medicines.
Further, these industries adhere to Good Manufacturing Practices (GMP) that
further assure accredited production, packaging and distribution. In that
sense, India has a relatively well-established regulatory framework for
Homoeopathy. However, the implementation of these Acts and Rules are sometimes
challenging at the end of the pharmaceutical industries, and despite their best
efforts to comply, some practical challenges remain that come in their way.
is one of the most followed medical systems in India and its strength lies in
the fact that its medicines are gentle, safe as well as cost-effective. In the
era of growing adverse drug reactions and auto-immune and lifestyle-related
illnesses, Homeopathy has a crucial role to play in the well-being of mankind.
The use of homoeopathy is steadily growing in India and as per an analysis by
Ministry of AYUSH, this sector exhibited an annual growth rate of 26.3% in the
past year, the highest among the other AYUSH modalities.